1-6 of 6
Alexis Visotcky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HJKC3-0006: Outcome of Patients with CML Treated on Second Line or Later Therapy in Routine Clinical Practice

James E Thompson, Yan Gao, Alexis Visotcky, Kathryn E Flynn, Michael Mauro, Emily Giever, Arielle Baim, Idayat Akinola, Richard Larson, Omer Jamy, Anthony M. Hunter, Vamsi K. Kota, Jorge Cortes, Brian J. Druker, Neil P. Shah, Javier Pinilla-Ibarz, Jay Yang, Ellen K. Ritchie, Lindsay A.M Rein, B. Douglas Smith, Srinivas K. Tantravahi, Talha Badar, Michael W. Deininger, Ehab L. Atallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 7420.
https://doi.org/10.1182/blood-2023-179963
Published: 2023
Journal Articles

HJKC3-007: Outcomes of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib and Other Tyrosine Kinase Inhibitors in Routine Clinical Practice

Michael Mauro, Ehab L. Atallah, James E Thompson, Yan Gao, Alexis Visotcky, Emily Giever, Arielle Baim, Idayat Akinola, Richard A. Larson, Omer Jamy, Jorge Cortes, Brian J. Druker, Neil P. Shah, Javier Pinilla-Ibarz, Jay Yang, Ellen K. Ritchie, Lindsay A.M Rein, Srinivas K. Tantravahi, Talha Badar, B. Douglas Smith, Michael W. Deininger, Kathryn E Flynn
Journal: Blood
Blood (2023) 142 (Supplement 1): 7434.
https://doi.org/10.1182/blood-2023-188683
Published: 2023
Journal Articles

Treatment Free Remission after Combination Therapy with Asciminib (ABL001) Plus Imatinib in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed after a Prior Attempt at TKI Discontinuation-H Jean Khoury Cure CML Consortium Study

Michael Mauro, Alexis Visotcky, Kathryn E Flynn, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Jorge E. Cortes, Vamsi K Kota, Srinivas K. Tantravahi, Arielle Baim, Mei-Jie Zhang, Alexander Hinman, Ehab L. Atallah, Kendra Sweet
Journal: Blood
Blood (2022) 140 (Supplement 1): 6765–6766.
https://doi.org/10.1182/blood-2022-160138
Published: 2022
Journal Articles

Asciminib As Initial Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)-H. Jean Khoury Cure CML Consortium Study

Ehab L. Atallah, Alexis Visotcky, Kathryn E Flynn, Mei-Jie Zhang, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Srinivas K. Tantravahi, B. Douglas Douglas Smith, Javier Pinilla Ibarz, Kendra Sweet, Michael Mauro, Brian J. Druker, James E. Thompson, Sonia Maldonado-Schmidt, Arielle Baim, Charles A. Schiffer, Vamsi K. Kota, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 3885–3886.
https://doi.org/10.1182/blood-2022-160172
Published: 2022
Journal Articles

Exploring Interest in and Feasibility of a Lifestyle Intervention for Multiple Myeloma Patients

Abigail Kerschner, Allen Hodge, Alexis Williams, Patrica Sheean, Kathleen Jensik, Alexis Visotcky, Parameswaran Hari, Meera Mohan, Saurabh Chhabra, Anita D'Souza, Melinda Stolley
Journal: Blood
Blood (2021) 138 (Supplement 1): 4018.
https://doi.org/10.1182/blood-2021-148134
Published: 2021
Journal Articles

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Saurabh Chhabra, MD, Parameswaran Hari, MD MRCP, MS, Alexis Visotcky, Nirav N Shah, MD, J. Douglas Rizzo, MD, Wael Saber, MD MS, Anita D'Souza, MBBS, Binod Dhakal, MBBS, Ashish Anshu, MS, PhD, Robert Thompson, Timothy S. Fenske, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, William R. Drobyski, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1974.
https://doi.org/10.1182/blood.V130.Suppl_1.1974.1974
Published: 2017